HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Lewis, H. Articles by Gaston, K. Search for Related Content PubMed PubMed Citation Articles by Lewis, H. Articles by Gaston, K. Agricola Articles by Lewis, H. Articles by Gaston, K.

Cellular transcription factors regulate human papillomavirus type 16 gene expression by binding to a subset of the DNA sequences recognized by the viral E2 protein

Department of Biochemistry, School of Medical Sciences, University of Bristol, University Walk, Bristol BS8 1TD, UK¹

Author for correspondence: Kevin Gaston.Fax +44 117 928 8274. e-mail Kevin.Gaston{at}Bristol.ac.uk

Human papillomavirus type 16 (HPV-16) is a DNA tumour virus that has been implicated in the development of cervical cancer. The HPV-16 E2 protein binds to four sites that are present upstream of the viral P97 promoter and regulates transcription of the E6 and E7 oncogenes. Here, it is shown that cellular transcription factors bind to two of these E2 sites. One cellular E2 site-binding factor, which is here named CEF-1, binds tightly to E2 site 1. CEF-2, an unrelated cellular E2 site-binding factor, binds tightly to E2 site 3. Transient transfection studies performed in the absence of the E2 protein showed that mutations that blocked the binding of CEF-1 to E2 site 1 or CEF-2 to E2 site 3 significantly reduced P97 promoter activity. Further characterization of CEF-1 indicated that this factor has not previously been identified and that CEF-1 and E2 competed for binding at E2 site 1.

This article has been cited by other articles:

				G Gallo, M Bibbo, L Bagella, A Zamparelli, F Sanseverino, M R Giovagnoli, A Vecchione, and A Giordano Study of viral integration of HPV-16 in young patients with LSIL J. Clin. Pathol., July 1, 2003; 56(7): 532 - 536. [Abstract] [Full Text] [PDF]

				C. D. Newhouse and S. J. Silverstein Orientation of a Novel DNA Binding Site Affects Human Papillomavirus-Mediated Transcription and Replication J. Virol., February 15, 2001; 75(4): 1722 - 1735. [Abstract] [Full Text]